Taking cues from convalescence to improve vaccines against hepatitis C virus
Hepatitis C virus (HCV) infection remains a worldwide public health issue despite direct-acting antivirals. A substantial proportion of infected individuals (15%–45%) spontaneously clear repeated HCV infections with genetically different viruses by generating broadly neutralizing antibodies (bNAbs)....
Main Authors: | Bharath K. Sreekumar, Taha Y. Taha, Melanie Ott |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2022-08-01
|
Series: | The Journal of Clinical Investigation |
Online Access: | https://doi.org/10.1172/JCI161819 |
Similar Items
-
Hepatitis C virus infects and perturbs liver stem cells
by: Nathan L. Meyers, et al.
Published: (2023-12-01) -
Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants
by: Daniel Sepulveda-Crespo, et al.
Published: (2020-06-01) -
Testing a vaccine candidate against Hepatitis C virus designed by combinatorial optimization
by: Iker Malaina, et al.
Published: (2023-12-01) -
Challenges and Prospects of Plant-Derived Oral Vaccines against Hepatitis B and C Viruses
by: Ana-Maria Madalina Pantazica, et al.
Published: (2021-09-01) -
Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus
by: Jason Gummow, et al.
Published: (2020-01-01)